About Index Trending news
Analyze
Pricing
Synoste Oy

Synoste Oy

Work at Synoste Oy? Add yourself to this profile

Synoste Oy

Synoste develops next-generation medical solutions for the treatment and correction of skeletal deformities. Its implants for lengthening limbs are based on a mechanism using smart metals that operate safely and painlessly for the patient.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital
Evonik Venture Capital GmbH
Venture capital (Series A)
$2,200,000
Finnvera Venture Capital, Lifeline Ventures, High-Tech Grunderfonds, +3
Employees

Team size

2
Locations
HQ
Headquarters
$2,200,000 Venture capital (Series A)
High-Tech Gründerfonds

Synoste Oy raises € 2.2 M in the first closing of A-round financing to acquire CE-approval for a next generation implant for correcting skeletal deformities

Venture capital
evonik

Venture Capital: Evonik invests in SYNOSTE, a medical technology start-up in Düsseldorf and Helsinki Industries - Specialty Chemicals